The effect of the triphosphate of 9-(2-hydroxyethoxymethyl)guanine (acyclovir, acycloguanosine) on cellular a deoxyribonucleic acid (DNA) polymerases (DNA nucleotidyltransferases), DNA polymerases of several members of the herpes group, vaccinia virus DNA polymerase, and Friend leukemia virus ribonucleic acid-dependent DNA polymerase was examined. Several viruses, which were found to be susceptible to acyclovir, were found to induce DNA polymerases which were sensitive to acyclovir triphosphate (acyclo-GTP). Human cytomegalovirus and the H29R strain of herpes simplex virus type 1, however, were found to be relatively insusceptible to acyclovir, even though their induced DNA polymerases were inhibited by low concentrations of acyclo-GTP. The amount of acyclovir anabolized to acyclo-GTP was significantly lower for human cytomegalovirus and H29R than for the more susceptible viruses. Vaccinia virus and Friend leukemia virus induced DNA polymerases which were insensitive to inhibition by low concentrations of acyclo-GTP, anabolized little acyclovir to acyclo-GTP, and were found to be insensitive to inhibition by acyclovir. Uninfected WI-38 cells were not susceptible to inhibition by acyclovir, anabolized little acyclovir to acyclo-GTP, and had an a DNA polymerase which was insensitive to inhibition by low concentrations of acyclo-GTP.
Considerable effort has been devoted to the discovery of chemical compounds which inhibit viral replication without affecting the normal cell functions. Elion et al. (8) and Schaeffer et al. (19) reported that the purine analog 9-(2-hydroxyethoxymethyl)guanine (acyclovir, acycloguanosine) is a potent antiherpetic agent which possesses extremely low cytotoxicity to uninfected cells. Acyclovir is an inhibitor of herpes simplex virus (HSV) deoxyribonucleic acid (DNA) synthesis, whereas the synthesis of Vero cell DNA is only partially inhibited at acyclovir concentrations several-hundred-fold greater than the 50% effective dose (ED5o) for HSV type 1 (HSV-1) (11) .
Acyclovir is anabolized to the monophosphate form by the viral thymidine kinase (8, 12) , after which it is converted to the diphosphate form by cellular guanosine monophosphate kinase (W. H. Miller and R. L. Miller, J. Biol. Chem., in press) and then to the triphosphate form, apparently by cellular enzymes. Elion et al. (8) and Furman et al. (11) reported that acyclovir triphosphate (acyclo-GTP) is an inhibitor of HSV-1 DNA polymerases (DNA nucleotidyltransferases) and, to a lesser extent, of cellular a DNA polymerases.
This report examines the ability of acyclo-GTP to inhibit the activity of several virus-induced and two cellular a DNA polymerases. The viruses represented include HSV-1 and -2, human cytomegalovirus (HCMV), vaccinia (20) . After strains of HSV-1, the MS and 333 strains of HSV-2, vaccinia virus, HCMV, and WI-38 a and L-929 a DNA polymerases were isolated and identified as described previously (8, 11, 13, 21) . FLV RNA-dependent DNA polymerase was isolated by homogenization and centrifugation of purified virions as described by Hurwitz and Leis (14) .
Polymerase assays. DNA polymerase assays were carried out as described by Elion et al. (8) RNA-dependent DNA polymerase was assayed by using the conditions described by Battula and Loeb (3). Activated calf thymus DNA served as the template. After incubation at 37°C, 20 gi of the 50-gl reaction mixture was transferred to DE-81 paper and processed as described above.
Chemical analyses. The acyclo-GTP content of infected and uninfected cells exposed to acyclovir was determined by high-pressure liquid chromatography. Cells infected with HSV-1, HSV-2, vaccinia virus, and FLV were treated with ['4C]acyclovir beginning at 1 h postinfection and harvested after 7 h of treatment. HCMV-infected WI-38 cells were treated for 7 h with ["C]acyclovir at 24 h postinfection. WI-38 and L-929 cells were also exposed to ["4C]acyclovir for 7 h. All cells were extracted and analyzed as described previously (8) .
The concentration of protein of the partially purified DNA polymerase samples was determined colorimetrically by the method of Bradford (5).
RESULTS
Inhibition of viral and cellular growth by acyclovir. The effect of acyclovir on viral and cell growth was determined. The results (Table  1) indicate that the H29 strain of HSV-1 was the most susceptible of the viruSes studied. The resistant strain, H29R, was approximately 100-fold less susceptible to acyclovir than was H29. The MS and 333 strains of HSV-2 had similar ED50's of 1.4 ,uM acyclovir. With ED5o's of greater than 100 MuM, HCMV, FLV, and vaccinia virus were essentially resistant to inhibition by acyclovir. Of the two cell lines studied, WI-38 was the more resistant, having an ED50 ofgreater than 1,000 M&M, whereas the ED50 for L-929 cells was 50,uM.
Formation of acyclo-GTP. Elion et al. (8) reported that the amount of acyclo-GTP fonned by cells incubated in the presence of ["C]acyclovir increased dramatically upon infection of the cells. The amount of acyclo-GTP formed was also found to be dependent upon the virus group and even upon the virus strain used when infecting the cells. To make a more meaningful correlation between EDso's and apparent Ki's it was, therefore, necessary to determine the amount of acyclovir anabolized to acyclo-GTP after infection by each of the virus strains studied.
When all of the virus-infected and uninfected cells were Table 2) . Inhibition of polymerase activity with acyclo-GTP. The effects of both acyclovir and its triphosphate on enzyme activity were studied. When the concentrations of the natural deoxynucleoside triphosphates were 100 ,uM, 20.9 ,uM acyclo-GTP inhibited the activity of 333 DNA polymerase by 66% after 15 min of incubation (Fig. 1) , and 209 ,uM acyclo-GTP inhibited the enzyme activity by greater than 99%. On the other hand, 131 t,M of the unphosphorylated compound had no effect on the same enzyme.
The Lineweaver-Burk plots obtained with the cellular a and viral DNA polymerases studied indicated competitive inhibition between dGTP and acyclo-GTP. Examples for polymerases induced by HSV-2 and vaccinia virus are given in Fig. 2 . The concentration of acyclo-GTP used with vaccinia virus DNA polymerase was approximately 10- in the reaction mixture ( Fig. 1) and preliminary evidence that acyclo-GTP incorporation may lead to enzyme or template inactivation or both (11) suggest that anomalies may exist in the kinetics of the inhibition. Therefore, only those datum points which represent the initial velocities were used in the Lineweaver-Burk plots, and inhibition constants were calculated by assuming normal enzyme kinetics. The DNA polymerases induced by HSV-1, HSV-2, and HCMV, having apparent Ki's which varied from 0.08 ± 0.03 to 0.56 ± 0.16 ,tM acyclo-GTP, were extremely sensitive to inhibition by acyclo-GTP. The DNA polymerases induced by vaccinia virus and FLV and the a DNA polymerases of WI-38 and L-929 cells, however, required much higher concentrations of acyclo-GTP to achieve the same degree of inhibition.
Vero cells infected with HSV-1 (strain H29) and incubated in the presence of a concentration of acyclovir twofold lower than the ED50 for H29 resulted in a cellular acyclo-GTP concentration 10-fold higher than the apparent Ki of the H29 DNA polymerase. In addition, when Vero cells infected with HSV-1 (strain H29R) or two strains of HSV-2 were incubated in a concentration of acyclovir approximating the respective ED5o's, the resulting acyclo-GTP content approached the apparent Ki's of the induced DNA polymerases. Inasmuch as the viral thymidine kinase is the enzyme responsible for the initial phosphorylation of acyclovir (8, 12) , and H29R thymidine kinase exhibits a 15-fold reduction in acyclovir phosphorylating activity compared with H29 (12), the resistance of H29R to acyclovir was not unexpected. on January 17, 2020 by guest http://aac.asm.org/ Downloaded from to inhibition by acyclo-GTP as were the DNA polymerases induced by HSV-1 and -2 (eg., Fig.  2 and Table 1 ). The DNA polymerase induced by HCMV was as sensitive to inhibition by acyclo-GTP as were the DNA polymerases induced by HSV. The resistance of HCMV to acyclovir appears to be due primarily to the absence of a virus-specified thymidine kinase (9) . Vaccinia virus, on the other hand, induces a thymidine kinase (15, 16) . However, Fyfe et al. (12) showed that the thymidine kinase induced by vaccinia virus was unable to phosphorylate acyclovir. FLV RNA-dependent DNA polymerase was virtually unaffected by acyclo-GTP, and FLV-infected FG-10 cells anabolized little acyclovir to acyclo-GTP. FLV, not unexpectedly, was also found to be resistant to inhibition by acyclovir.
WI-38 cells were found to be extremely resistant to inhibition by acyclovir, whereas the ED50 for L-929 cells was only 50 ,M. L-929 cells formed 20-fold more acyclo-GTP than did WI-38 cells when treated with the same concentration of acyclovir. The low ED50 for L-929 cells was consistent with the ED50's observed for other mouse cell lines (10, 18) .
The fact that low concentrations of acyclo-GTP inhibited HSV-induced DNA polymerases although even large amounts of the unphosphorylated form of the compound had no effect on 333 DNA polymerase indicated that acyclovir must be phosphorylated to the triphosphate form before the activity of the viral DNA polymerase will be inhibited. Inhibitory concentrations of the triphosphate are dependent upon the formation of sufficient amounts of acyclovir monophosphate. Therefore, the viral susceptibility to acyclovir depends not only on the sensitivity of the virus-induced DNA polymerase to inhibition by acyclo-GTP, but also on the presence of a nucleoside kinase capable of phosphorylating acyclovir and on the presence of cellular enzymes which convert the monophosphate to the triphosphate.
